MC-5A for Chemotherapy Induced Peripheral Neuropathy
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Painful chemotherapy induced peripheral neuropathy (CIPN) is a common complication of cancer
therapy with few treatment options. CIPN is a complex side effect that varies between
individuals and can be difficult to describe, difficult to treat and can significantly effect
quality of life for patients.
The purpose of this study is to determine if patients with painful CIPN will have a decrease
in pain scores after treatment with the MC-5A device.